Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

A technology that diagnoses diseases such as Alzheimer’s and Parkinson’s using just a few drops of blood from a finger prick ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

AUSTIN, Texas--(BUSINESS WIRE)--BetterWay™ blood testing by Babson Diagnostics was announced the winner in the Health and Biotech category of the prestigious 26 th Annual SXSW® Innovation Awards ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

UK-based blood testing company Thriva has joined forces with medical device manufacturer Tasso to use their innovative blood testing technology to tackle needle phobia, a condition that affects at ...

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...

New blood-testing technology that promises to improve healthcare treatments for cancer patients, post-operative care and monitor the health of babies in the womb is being developed by Lancaster ...

New fingertip blood testing technology, developed by Babson Diagnostics, takes home coveted prize in the health and biotech category BetterWay™ blood testing by Babson Diagnostics was announced the ...